Stage I Grade 3 Follicular Lymphoma Terminated Phase 1 Trials for Lenalidomide (DB00480)

IndicationStatusPhase
DBCOND0029477 (Stage I Grade 3 Follicular Lymphoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01045928Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin LymphomaTreatment